Skip to main content

  • ARNI on Par With Other HFrEF Strategies for Saving Lives Long Term

    • Posted: 11/30/2018
    • Author:

      Ashley Lyles, Staff Writer, MedPage Today

    • 2018News Articles

    Sacubitril/valsartan yields "comparable" number needed to treat at 5 years

    The 5-year estimated number needed to treat (NNT) for sacubitril/valsartan (Entresto) in the PARADIGM-HF trial was on par with that from other pivotal trials in heart failure with reduced ejection fraction (HFrEF), researchers found.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details